ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Determinants of Acquired Endocrine Resistance in Metastatic Breast Cancer: A Pilot Study
- Status
- UNKNOWN
- Phase
- N/A
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Letrozole and Metronomic Capecitabine in ER-positive HER2 Negative Advanced Breast Cancer (B-001 Study)
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Phase 1b/2 Study of T-DXd Combinations in HER2-positive Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Real World Study Using Comprehensive Genomic Data on the Next Treatment Decision Making in Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Metastases-directed Radiotherapy in Addition to Standard Systemic Therapy in Patients With Oligometastatic Breast Cancer
- Status
- COMPLETED
- Phase
- NA
A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Evaluation of Lasofoxifene Combined With Abemaciclib in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
- Status
- COMPLETED
- Phase
- PHASE2
Early Interim 18F-FDG-PET and 18F-FLT-PET for Predicting Treatment Response and Survival in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- NA
First Line Atezolizumab, Paclitaxel, and Bevacizumab (Avastin®) in mTNBC
- Status
- COMPLETED
- Phase
- PHASE2
Pyrotinib in Combination With Letrozole in Patients With HER2-Positive, ER-Positive Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Safety and Efficacy of Toripalimab in HER2- Metastatic Breast Cancer Patients Treated With Metronomic Vinorelbine
- Status
- UNKNOWN
- Phase
- PHASE2
B002 in Patients With HER2-positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Optimizing Quality of Life in Women Living With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Characterization of Innate Immune System in Patients With Luminal Advanced Breast Cancer
- Status
- TERMINATED
- Phase
- N/A
Pharmacokinetic Study of Pyrotinib and Docetaxel in Combination With Trastuzumab in Patients With HER2 Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1